Action | Initial regulations |
Stage | Proposed |
Comment Period | Ended on 1/26/2018 |
19 comments
I have a problem not with this law but with the cost to me and my insurance company, that I will explain in hopes of finding a solution. A brief Background:
I’m a 62 year old female I have documented cases of Arthritis, Sjogrens Syndrome, I also have had a pelvic sling which went very badly. These left me immobile due to swelling and pain, this was for the best part of two years. I was self-medicating with a lot Excedrin to be able to perform the smallest of daily living. My doctor that did the pelvic sling told me there was nothing else he could do for me. Two years ago my blood count bottomed out and I was hospitalized with only 4000 platelets which was life threatening.
Since that time several wonderful doctors have given me my life back. The medications and the doses were all trial and error to get to this point. I’m building myself back up and enjoying doing things with my children and grandchildren again. I am able to hold down my job now with the Virginia Employment Commission (pay band three.)
This new law that is in affect that states that I have to take a drug test every so often. I do not mind doing this. I took time off from my job and paid for an office visit that I didn’t need. My doctor did the test and it was sent to Labcorp. The test came back as expected. Then I get a bill for the test at the cost of $221.00 for my part of the test and the insurance had to pay the remainder of the $425.00. I will still need to purchase the Medication. This something that I cannot afford and I certainly hate to go into debt for. I only take one Tramadol or two a day along with the other medications not on your list.
I hope you can see the issue I take with this Law. There are others I feel sure that are on a fixed income for example the elderly, terminally ill, cancer patients etc. that this will impact greatly. Again the elderly and the lower income population will not be able to received proper care.
I would be happy to speak to someone further.
Melissa Messick
lion6255@aol.com
While I agree with the spirit of the law, please reduce the cost of testing.
As a teen, my parents have told me that I will not get the same dose or amount of pain meds I had in the past because docs are afraid to help kids like me it's not right.
It is very important that sickle cell patients continue to receive an adequate dosage of pain medications that has previously been recommended by their physician. Recently I have spoken to several relatives of sickle cell patients and they are very concerned about the cut back of much needed pain medication relative to the pain that is experience with this health problem.
Please ensure that Sickle Cell Disease be made an exception to the guidelines.
Im asking that Sickle Cell Disease be made an exception to the guidelines of opioid prescriptions.
Please make Sickle Cell Disease an exception to the opiod guidelines. Thank you.
William L. Harp, M.D. January 18, 2018
Executive Director
Board of Medicine
9960 Mayland Drive, Suite 300
Richmond, VA 23233
RE: Regulations Governing Prescribing of Opioids and Buprenorphine
Dear Dr. Harp:
The Medical Society of Virginia (MSV) appreciates the opportunity to comment on the Regulations Governing Prescribing of Opioids and Buprenorphine (18 VAC 85-21). MSV commends the Board’s work in developing strong regulations that reflect prescribing best practices while ensuring the flexibility of professional judgment in extenuating medical circumstances.
MSV supported the Board’s development of the initial emergency opioid and buprenorphine prescribing regulations enacted in March 2017. The emergency regulations provided a comprehensive framework of best practices that included consideration of non-opioid treatments, querying the Prescription Monitoring Program, appropriate strength, length, and quantity supply parameters, family history, treatment plans, and recognition of special considerations and populations. This multi-faceted approach to opioid and buprenorphine prescribing gave prescribers appropriate guidance for the multiple factors that can contribute to opioid addiction, while preserving an option to treat extenuating medical circumstances.
These efforts by the Board and other partners to recognize, treat, and prevent opioid addiction have had a positive impact on the Commonwealth. In the past year, the number of individuals receiving high doses of opioids decreased by 18.6%, opioid doses declined by 40.15%, and multiple provider episodes per 100,000 Virginia residents decreased by 45%.
To continue Virginia’s progress in aligning with prescribing best practices, MSV supports enacting 18 VAC 85-21. MSV is dedicated to reducing opioid addiction in Virginia by partnering with the Board and other state government agencies and stakeholder groups and by providing prescribing resources to physicians. MSV’s opioid resource webpage gives physicians access to prescribing tools, best practice guidelines, and continuing education resources: http://www.msv.org/opioids.
MSV extends its support of the Board in its attention to the opioid crisis and is dedicated to working together.
Sincerely,
Melina Davis-Martin
Executive Vice President
CC:
David Brown, D.C., Director, Department of Health Professions
Elaine Yeatts, Policy Analyst, Department of Health Professions
Scott Johnson, General Counsel, MSV
Lauren Bates-Rowe, Assistant Vice President of Health Policy, MSV
Ralston King, Assistant Vice President of Government Affairs, MSV
I have 2 boys with Sickle Cell Disease. I support regulations to control the abuse of opiods but not at the expense of Sickle Cell patients. Some, not all require available medication that goes beyond the current allowable limits to support there pain management at home or after a hospitalization. There pain management is suffering with the limits proposed and will in effect cause more ER visits which could have been avoided.
Please make Sickle Cell Disease an exception to the opiod guidelines. I thank you and my children that you.
Ronald Dews Jr.
I would also like the treatment of pain in patients with sickle cell disease to be an exception. Many of these patients live with chronic pain with acute exacerbations they can manage at home. Limitations on dosing would hinder their ability to do this and would send them to the ED, which typically would be either unnecessary or an overtreatment of something they could have handled at home. Even managing children with sickle cell disease with these limitations is challenging. I also think it is very important that patients with chronic pain know they have medicine when needed.
Due to the national opioid crisis, last year the Virginia Board of Medicine put emergency guideline/rules in place for doctors to follow when they prescribe opioids to all of their patients. Those guidelines include limits on dosage and long acting opioids needed by sickle cell patients, but they make NO rule exception for persons suffering from the pain crisis of sickle cell.
Please make Sickle Cell Disease an exception to the guidelines.
Thank you,
Kimberly F. Johnson
Please make an exception for Sicle Cell Patients to be allowed access to this medication for their health condition.